Fort L.P. raised its holdings in CVS Health Corp (NYSE:CVS) by 340.4% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 169,356 shares of the pharmacy operator’s stock after purchasing an additional 130,905 shares during the quarter. CVS Health makes up about 3.4% of Fort L.P.’s investment portfolio, making the stock its 13th largest position. Fort L.P.’s holdings in CVS Health were worth $13,772,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also modified their holdings of the company. Fieldpoint Private Securities LLC raised its position in shares of CVS Health by 333.3% during the second quarter. Fieldpoint Private Securities LLC now owns 1,300 shares of the pharmacy operator’s stock worth $105,000 after acquiring an additional 1,000 shares during the last quarter. Arcadia Investment Management Corp MI grew its stake in shares of CVS Health by 119.6% during the third quarter. Arcadia Investment Management Corp MI now owns 1,333 shares of the pharmacy operator’s stock worth $108,000 after purchasing an additional 726 shares during the period. MPS Loria Financial Planners LLC acquired a new stake in shares of CVS Health during the second quarter worth $119,000. Captrust Financial Advisors acquired a new stake in shares of CVS Health during the second quarter worth $155,000. Finally, Howe & Rusling Inc. grew its stake in shares of CVS Health by 5,084.2% during the third quarter. Howe & Rusling Inc. now owns 1,970 shares of the pharmacy operator’s stock worth $160,000 after purchasing an additional 1,932 shares during the period. Hedge funds and other institutional investors own 81.64% of the company’s stock.

A number of brokerages recently commented on CVS. Loop Capital decreased their price objective on CVS Health from $83.00 to $73.00 and set a “hold” rating for the company in a research note on Tuesday, November 7th. Morgan Stanley raised CVS Health from an “equal weight” rating to an “overweight” rating and set a $88.00 price objective for the company in a research note on Friday, January 5th. Needham & Company LLC lifted their price objective on CVS Health from $85.00 to $88.00 and gave the stock a “buy” rating in a research note on Tuesday, January 2nd. SunTrust Banks lifted their price objective on CVS Health to $90.00 and gave the stock a “buy” rating in a research note on Friday, January 5th. Finally, Mizuho set a $95.00 price objective on CVS Health and gave the stock a “buy” rating in a research note on Wednesday, January 24th. Two investment analysts have rated the stock with a sell rating, eight have issued a hold rating, twelve have given a buy rating and two have assigned a strong buy rating to the company’s stock. CVS Health presently has a consensus rating of “Buy” and an average target price of $87.49.

In other news, EVP Lisa Bisaccia sold 29,445 shares of the business’s stock in a transaction dated Thursday, December 21st. The stock was sold at an average price of $75.00, for a total value of $2,208,375.00. Following the sale, the executive vice president now directly owns 15,556 shares in the company, valued at $1,166,700. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. 0.61% of the stock is currently owned by insiders.

CVS Health Corp (NYSE:CVS) opened at $83.63 on Tuesday. CVS Health Corp has a 52 week low of $66.45 and a 52 week high of $84.00. The company has a quick ratio of 0.55, a current ratio of 1.05 and a debt-to-equity ratio of 0.67. The stock has a market capitalization of $83,075.48, a PE ratio of 14.36, a price-to-earnings-growth ratio of 1.29 and a beta of 0.90.

CVS Health (NYSE:CVS) last posted its earnings results on Monday, November 6th. The pharmacy operator reported $1.50 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.49 by $0.01. CVS Health had a return on equity of 16.96% and a net margin of 2.77%. The firm had revenue of $46.18 billion during the quarter, compared to analysts’ expectations of $46.17 billion. During the same period in the previous year, the firm earned $1.64 earnings per share. The company’s revenue was up 3.5% on a year-over-year basis. equities research analysts predict that CVS Health Corp will post 5.88 EPS for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 2nd. Shareholders of record on Wednesday, January 24th will be paid a $0.50 dividend. The ex-dividend date of this dividend is Tuesday, January 23rd. This represents a $2.00 dividend on an annualized basis and a yield of 2.39%. CVS Health’s payout ratio is 41.32%.

COPYRIGHT VIOLATION WARNING: This news story was originally posted by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are reading this news story on another domain, it was illegally stolen and republished in violation of U.S. & international copyright legislation. The original version of this news story can be read at https://theolympiareport.com/2018/01/30/cvs-health-corp-cvs-shares-bought-by-fort-l-p.html.

CVS Health Profile

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corp (NYSE:CVS).

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.